Insulet
PODD
#1968
Rank
A$15.07 B
Marketcap
A$217.36
Share price
0.87%
Change (1 day)
-56.71%
Change (1 year)
Categories
Insulet Corporation is an American company that develops and sells medical devices used for the administration of insulin.

EPS for Insulet (PODD)

EPS in 2026 (TTM): A$8.66

According to Insulet's latest financial reports the company's current EPS (TTM) is A$8.81. In 2024 the company made an earnings per share (EPS) of A$8.87 an increase over its 2023 EPS that were of A$4.38.

EPS history for Insulet from 2011 to 2026

Annual EPS

Year EPS Change
2026 (TTM)A$8.66
2024A$8.87102.71%
2023A$4.384114.29%
2022A$0.10-69.57%
2021A$0.34109.09%
2020A$0.16-38.89%
2019A$0.27200%
2018A$0.08899-113.04%
2017A-$0.68-9.8%
2016A-$0.76-60.47%
2015A-$1.9138.71%
2014A-$1.3812.05%
2013A-$1.23-23.15%
2012A-$1.60-12.2%
2011A-$1.82

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Johnson & Johnson
JNJ
A$9.91 12.46%๐Ÿ‡บ๐Ÿ‡ธ USA
Abbott Laboratories
ABT
A$4.01-54.48%๐Ÿ‡บ๐Ÿ‡ธ USA
Medtronic
MDT
A$6.05-31.31%๐Ÿ‡ฎ๐Ÿ‡ช Ireland
Eli Lilly
LLY
A$45.82 420.05%๐Ÿ‡บ๐Ÿ‡ธ USA
Tandem Diabetes Care
TNDM
A-$1.38-115.66%๐Ÿ‡บ๐Ÿ‡ธ USA
ICU Medical
ICUI
A$1.78-79.80%๐Ÿ‡บ๐Ÿ‡ธ USA
DexCom
DXCM
A$3.84-56.40%๐Ÿ‡บ๐Ÿ‡ธ USA